Jacqueline Aredo, MD, MS
RESIDENT
Medicine
School of Medicine

Publications (32)

Top publication keywords:
Myofascial Pain SyndromesBiomarkers, PharmacologicalMutationNeoplasms, Second PrimaryNeoplasms, Multiple PrimaryEndometriosisConsolidation ChemotherapyCentral Nervous System SensitizationEarly Detection of CancerPelvic PainErbB ReceptorsCarcinoma, Non-Small-Cell LungLung NeoplasmsProto-Oncogene Proteins c-retProto-Oncogene Proteins p21(ras)

• Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort Study.
  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2024 Nassar AH, Kim SY, Aredo JV, Feng J, Shepherd F, Xu C, Kaldas D, Gray JE, Dilling TJ, Neal JW, Wakelee HA, Liu Y, Lin SH, Abuali T, Amini A, Nie Y, Patil T, Lobachov A, Bar J, Fitzgerald B, Fujiwara Y…
• Risk Model-Based Lung Cancer Screening and Racial and Ethnic Disparities in the US.
  JAMA oncology 2023 Choi E, Ding VY, Luo SJ, Ten Haaf K, Wu JT, Aredo JV, Wilkens LR, Freedman ND, Backhus LM, Leung AN, Meza R, Lui NS, Haiman CA, Park SL, Le Marchand L, Neal JW, Cheng I, Wakelee HA, Tammemägi MC, Han …
• Second Primary Lung Cancer Among Lung Cancer Survivors Who Never Smoked.
  JAMA network open 2023 Choi E, Su CC, Wu JT, Aredo JV, Neal JW, Leung AN, Backhus LM, Lui NS, Le Marchand L, Stram DO, Liang SY, Cheng I, Wakelee HA, Han SS
• Risk model-based management for second primary lung cancer among lung cancer survivors through a validated risk prediction model.
  Cancer 2023 Choi E, Luo SJ, Ding VY, Wu JT, Kumar AV, Wampfler J, Tammemägi MC, Wilkens LR, Aredo JV, Backhus LM, Neal JW, Leung AN, Freedman ND, Hung RJ, Amos CI, Le Marchand L, Cheng I, Wakelee HA, Yang P, Han …
• Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC.
  Cancer discovery 2023 Negrao MV, Araujo HA, Lamberti G, Cooper AJ, Akhave NS, Zhou T, Delasos L, Hicks JK, Aldea M, Minuti G, Hines J, Aredo JV, Dennis MJ, Chakrabarti T, Scott SC, Bironzo P, Scheffler M, Christopoulos P, …

Show all (27 more) Hide

• Efficacy of Osimertinib in Patients with Lung Cancer Positive for Uncommon EGFR Exon 19 Deletion Mutations.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2023 Grant MJ, Aredo JV, Starrett JH, Stockhammer P, van Alderwerelt van Rosenburgh IK, Wurtz A, Piper-Valillo AJ, Piotrowska Z, Falcon C, Yu HA, Aggarwal C, Scholes D, Patil T, Nguyen C, Phadke M, Li FY, …
• Implementation and evaluation of an elective quality improvement curriculum for preclinical students: a prospective controlled study.
  BMC medical education 2023 Aredo JV, Ding JB, Lai CH, Trimble R, Bromley-Dulfano RA, Popat RA, Shieh L
• Osimertinib in NSCLC With Atypical EGFR-Activating Mutations: A Retrospective Multicenter Study.
  JTO clinical and research reports 2023 Ji J, Aredo JV, Piper-Vallillo A, Huppert L, Rotow JK, Husain H, Stewart S, Cobb R, Wakelee HA, Blakely CM, Wong ML, Gubens MA, Madani MH, Digumarthy SR, McCoach C, Piotrowska Z, Neal JW, Riess JW
• Induction EGFR tyrosine kinase inhibitors prior to definitive chemoradiotherapy in unresectable stage III EGFR-mutated non-small cell lung cancer.
  Cancer treatment and research communications 2022 Aredo JV, Wakelee HA, Hui AB, Padda SK, Joshi ND, Guo HH, Chaudhuri A, Diehn M, Loo BW, Neal JW
• Racial and Ethnic Disparities in Lung Cancer Screening by the 2021 USPSTF Guidelines Versus Risk-Based Criteria: The Multiethnic Cohort Study.
  JNCI cancer spectrum 2022 Aredo JV, Choi E, Ding VY, Tammemägi MC, Ten Haaf K, Luo SJ, Freedman ND, Wilkens LR, Le Marchand L, Wakelee HA, Meza R, Park SL, Cheng I, Han SS
• High-Dose Osimertinib for CNS Progression in EGFR+ NSCLC: A Multi-Institutional Experience.
  JTO clinical and research reports 2022 Piper-Vallillo AJ, Rotow JK, Aredo JV, Shaverdashvili K, Luo J, Carlisle JW, Husain H, Muzikansky A, Heist RS, Rangachari D, Ramalingam SS, Wakelee HA, Yu HA, Sequist LV, Bauml JM, Neal JW, Piotrowska…
• The Survival Impact of Second Primary Lung Cancer in Patients With Lung Cancer.
  Journal of the National Cancer Institute 2022 Choi E, Luo SJ, Aredo JV, Backhus LM, Wilkens LR, Su CC, Neal JW, Le Marchand L, Cheng I, Wakelee HA, Han SS
• Development and Validation of a Risk Prediction Model for Second Primary Lung Cancer.
  Journal of the National Cancer Institute 2022 Choi E, Sanyal N, Ding VY, Gardner RM, Aredo JV, Lee J, Wu JT, Hickey TP, Barrett B, Riley TL, Wilkens LR, Leung AN, Le Marchand L, Tammemägi MC, Hung RJ, Amos CI, Freedman ND, Cheng I, Wakelee HA, …
• Afatinib After Progression on Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer.
  Cancer treatment and research communications 2021 Aredo JV, Wakelee HA, Neal JW, Padda SK
• Consolidation Durvalumab Should Not Be Administered to Patients With Stage III EGFR-Mutant NSCLC.
  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2021 Aredo JV, Hellyer JA, Neal JW, Wakelee HA
• Computational Biological Modeling Identifies PD-(L)1 Immunotherapy Sensitivity Among Molecular Subgroups of KRAS-Mutated Non-Small-Cell Lung Cancer.
  JCO precision oncology 2021 Padda SK, Aredo JV, Vali S, Singh NK, Vasista SM, Kumar A, Neal JW, Abbasi T, Wakelee HA
• Smoking Cessation After Lung Cancer Diagnosis and the Risk of Second Primary Lung Cancer: The Multiethnic Cohort Study.
  JNCI cancer spectrum 2021 Luo SJ, Choi E, Aredo JV, Wilkens LR, Tammemägi MC, Le Marchand L, Cheng I, Wakelee HA, Han SS
• A Moving Target: Integration of Smoking Cessation Into Screening for Second Primary Lung Cancer.
  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2021 Aredo JV, Wakelee HA, Han SS
• EGFR exon 20 Insertion NSCLC and Response to Platinum-Based Chemotherapy.
  Clinical lung cancer 2021 Shah MP, Aredo JV, Padda SK, Ramchandran KJ, Wakelee HA, Das MS, Neal JW
• Tobacco Smoking and Risk of Second Primary Lung Cancer.
  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2021 Aredo JV, Luo SJ, Gardner RM, Sanyal N, Choi E, Hickey TP, Riley TL, Huang WY, Kurian AW, Leung AN, Wilkens LR, Robbins HA, Riboli E, Kaaks R, Tjønneland A, Vermeulen RCH, Panico S, Le Marchand L, …
• Metabolomic profiling for second primary lung cancer: A pilot case-control study.
  Lung cancer (Amsterdam, Netherlands) 2021 Aredo JV, Purington N, Su L, Luo SJ, Diao N, Christiani DC, Wakelee HA, Han SS
• Durvalumab for Stage III EGFR-Mutated NSCLC After Definitive Chemoradiotherapy.
  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2021 Aredo JV, Mambetsariev I, Hellyer JA, Amini A, Neal JW, Padda SK, McCoach CE, Riess JW, Cabebe EC, Naidoo J, Abuali T, Salgia R, Loo BW, Diehn M, Han SS, Wakelee HA
• Role of Consolidation Durvalumab in Patients With EGFR- and HER2-Mutant Unresectable Stage III NSCLC.
  Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2021 Hellyer JA, Aredo JV, Das M, Ramchandran K, Padda SK, Neal JW, Wakelee HA
• Widespread myofascial dysfunction and sensitisation in women with endometriosis-associated chronic pelvic pain: A cross-sectional study.
  European journal of pain (London, England) 2021 Phan VT, Stratton P, Tandon HK, Sinaii N, Aredo JV, Karp BI, Merideth MA, Shah JP
• Targeted Treatment of Multiple Primary Lung Cancers Harboring Distinct EGFR or RET Alterations: A Case Report.
  Clinical lung cancer 2020 Aredo JV, Diehn M, Berry GJ, Wakelee HA
• Response to comment on "Impact of KRAS mutation subtype and concurrent pathogenic mutations on non-small cell lung cancer outcomes".
  Lung cancer (Amsterdam, Netherlands) 2019 Aredo JV, Padda SK, Kunder CA, Han SS, Neal JW, Shrager JB, Wakelee HA
• Impact of KRAS mutation subtype and concurrent pathogenic mutations on non-small cell lung cancer outcomes.
  Lung cancer (Amsterdam, Netherlands) 2019 Aredo JV, Padda SK, Kunder CA, Han SS, Neal JW, Shrager JB, Wakelee HA
• Epidermal Growth Factor Receptor Mutation Status Confers Survival Benefit in Patients with Non-Small-Cell Lung Cancer Undergoing Surgical Resection of Brain Metastases: A Retrospective Cohort Study.
  World neurosurgery 2019 Huang Y, Chow KKH, Aredo JV, Padda SK, Han SS, Kakusa BW, Hayden Gephart M
• Management of KRAS-Mutant Non-Small Cell Lung Cancer in the Era of Precision Medicine.
  Current treatment options in oncology 2018 Aredo JV, Padda SK
• Relating Chronic Pelvic Pain and Endometriosis to Signs of Sensitization and Myofascial Pain and Dysfunction.
  Seminars in reproductive medicine 2017 Aredo JV, Heyrana KJ, Karp BI, Shah JP, Stratton P
• Beneficial Effects of Dry Needling for Treatment of Chronic Myofascial Pain Persist for 6 Weeks After Treatment Completion.
  PM & R : the journal of injury, function, and rehabilitation 2016 Gerber LH, Sikdar S, Aredo JV, Armstrong K, Rosenberger WF, Shao H, Shah JP
• Myofascial Trigger Points Then and Now: A Historical and Scientific Perspective.
  PM & R : the journal of injury, function, and rehabilitation 2015 Shah JP, Thaker N, Heimur J, Aredo JV, Sikdar S, Gerber L